Literature DB >> 28084205

Tuberculous Lymphadenitis and Parotitis.

Juan Carlos Cataño1, Jaime Robledo2.   

Abstract

Tuberculous lymphadenitis is the most common extrapulmonary manifestation of disseminated tuberculosis (TB). It is considered to be the local manifestation of the systemic disease that has disseminated to local lymph nodes, but a high index of suspicion is needed for the diagnosis, because there are several infectious and noninfectious diseases that can mimic the same clinical picture. In recent years, different diagnostic methods have been introduced, including fine-needle aspiration cytology, which has emerged as a simple outpatient diagnostic procedure that replaced the complete excisional node biopsy, and a number of molecular methods which have greatly improved diagnostic accuracy. This chapter covers the most actual knowledge in terms of epidemiology, clinical manifestations, pathogenesis, and treatment and emphasizes current trends in diagnosis of tuberculous lymphadenitis. TB parotid gland involvement is extremely rare, even in countries in which TB is endemic. Because of the clinical similarity, parotid malignancy and other forms of parotid inflammatory disease always take priority over the rarely encountered TB parotitis when it comes to differential diagnosis. As a result, clinicians often fail to make a timely diagnosis of TB parotitis when facing a patient with a slowly growing parotid lump. This chapter highlights the most important features of this uncommon disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28084205     DOI: 10.1128/microbiolspec.TNMI7-0008-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  5 in total

1.  Value of Contrast-Enhanced Ultrasound in the Ultrasound Classification of Cervical Tuberculous Lymphadenitis.

Authors:  Ying Zhang; Tianzhuo Yu; Dongming Su; Wei Tang; Gaoyi Yang
Journal:  Front Med (Lausanne)       Date:  2022-06-14

2.  Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis.

Authors:  Daniel Mekonnen; Awoke Derbie; Andargachew Abeje; Abebe Shumet; Endalkachew Nibret; Fantahun Biadglegne; Abaineh Munshae; Kidist Bobosha; Liya Wassie; Stefan Berg; Abraham Aseffa
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

3.  Clinical Characteristics and Treatment Outcomes of Definitive Versus Standard Anti-Tuberculosis Therapy in Patients with Tuberculous Lymphadenitis.

Authors:  Yousang Ko; Changwhan Kim; Yong Bum Park; Eun-Kyung Mo; Jin-Wook Moon; Sunghoon Park; Yun Su Sim; Ji Young Hong; Moon Seong Baek
Journal:  J Clin Med       Date:  2019-06-07       Impact factor: 4.241

4.  Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis.

Authors:  Gokul Raj Kathamuthu; Kadar Moideen; Rathinam Sridhar; Dhanaraj Baskaran; Subash Babu
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

5.  Cervical Lymphadenopathy in a Nonagenarian Woman: What to Think?

Authors:  Vanessa Meireles Chaves; Fernando Miguel Miranda Nogueira; Gilberto Pires da Rosa; Sofia Tavares; Inês Ferreira; Ana Oliveira Monteiro; Ester Maria Morgado Ferreira
Journal:  Eur J Case Rep Intern Med       Date:  2019-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.